pharmaceutical - International Biopharmaceutical Industry

Volume 5 Issue 3

Pro-Electrophiles A Previously Overlooked Class of Protein-reactive Extractables?

Extractable and leachable studies on primary packaging systems are well-established in the pharmaceutical industry. For extraction studies, guidelines and best practi...

12 October 2022 Volume 5 Issue 3 active | best practice

Continue Reading →

news

Drug price hikes moderate as rebates rise, report finds

Dive Brief: List prices of branded drugs in the U.S. rose by an average of nearly 5% last year, according to a report released Thursday by Iqvia, a consultancy and...

25 April 2022 news COVID-19 | Drug

Continue Reading →

news

CHARNWOOD MOLECULAR UNVEILS CUTTING EDGE LABORATORIES

Charnwood Molecular, a leading UK-based pre-clinical discovery CRO serving the global pharmaceutical and biotechnology market, has officially opened its new facilitie...

8 April 2022 news biotechnology | Charnwood

Continue Reading →

Volume 4 Issue 4

Contamination Control Strategy

Regulatory bodies expect that pharmaceutical companies have a Contamination Control Strategy (CCS) in place that outlines the control of contamination of utilities, m...

9 December 2021 Volume 4 Issue 4 CCS | Contamination Control Strategy

Continue Reading →

news

AstraZeneca builds case for long-acting COVID-19 drug, but is it too late?

In some ways, AstraZeneca's COVID-19 response has been as good as any in the biopharmaceutical industry. The British drugmaker licensed and developed an effective CO...

15 October 2021 news AstraZeneca | AZD7442

Continue Reading →

news

AstraZeneca strikes deal with university spinoff to turn RNA into drugs

The success of the mRNA vaccines developed by Moderna and BioNTech has drawn significant attention, and new funding, to the technology that allows drug developers to ...

30 September 2021 news AstraZeneca | BioNTech

Continue Reading →

news

Sanofi to buy Kadmon for $1.9B, extending deal streak

Sanofi has agreed to buy Kadmon Holdings for $1.9 billion, the latest in a string of acquisitions the French pharmaceutical giant has used to add new drugs and techno...

10 September 2021 news drugs and technologies | Kadmon

Continue Reading →

news

How Bayer lured a biotech away from an IPO and into a buyout

In what has become a common move by large pharmaceutical companies attempting to revitalize their drug research, German healthcare conglomerate Bayer has acquired a s...

13 August 2021 news Bayer | Biotech

Continue Reading →

news

Pfizer’s fast progress shines spotlight on an emerging vaccine race

Drugmakers have laboured for decades to successfully develop a vaccine to protect infants and older people against infections of a common pathogen called respiratory ...

5 August 2021 news drugmakers | GlaxoSmithKline

Continue Reading →

A-D

Biopharma Group

The Biopharma Group comprises of Biopharma Process Systems (BPS), Biopharma Technologies Ltd (BTL), Biopharma Technology LLC (USA) and Biopharma Technologies France (...

31 May 2018 A-D biopharma | Biotech

Continue Reading →

Current Edition

Upcoming Events

Advertisement

Pro-Electrophiles A Previously Overlooked Class of Protein-reactive Extractables?

Drug price hikes moderate as rebates rise, report finds

CHARNWOOD MOLECULAR UNVEILS CUTTING EDGE LABORATORIES

Contamination Control Strategy

AstraZeneca builds case for long-acting COVID-19 drug, but is it too late?

AstraZeneca strikes deal with university spinoff to turn RNA into drugs

Sanofi to buy Kadmon for $1.9B, extending deal streak

How Bayer lured a biotech away from an IPO and into a buyout

Pfizer’s fast progress shines spotlight on an emerging vaccine race

Biopharma Group

International Biopharmaceutical Industry